Serum chemokine levels in major depressive disorder

Psychoneuroendocrinology

Volumn 35, Issue 2, 2010, Pages 226-232

  Lehto, Soili M ^a,b   Niskanen, Leo ^a   Herzig, Karl Heinz ^a,c   Tolmunen, Tommi ^a   Huotari, Anne ^c   Viinamäki, Heimo ^a   Koivumaa Honkanen, Heli ^a,c,d   Honkalampi, Kirsi ^b   Ruotsalainen, Heli ^c   Hintikka, Jukka ^a  

^a KUOPIO UNIVERSITY HOSPITAL   (Finland)

^b Kuopio Psychiatric Center   (Finland)

^c UNIVERSITY OF OULU   (Finland)

^d LAPLAND CENTRAL HOSPITAL   (Finland)

Author keywords

Chemokines; IL 8; Inflammation; Major depressive disorder; MCP 1; MIP 1

Indexed keywords

ANTIDEPRESSANT AGENT; ANXIOLYTIC AGENT; C REACTIVE PROTEIN; INTERLEUKIN 8; MACROPHAGE INFLAMMATORY PROTEIN 1BETA; MONOCYTE CHEMOTACTIC PROTEIN 1; NEUROLEPTIC AGENT;

ADULT; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE SEVERITY; DOWN REGULATION; FEMALE; HAMILTON SCALE; HUMAN; INFLAMMATION; MAJOR CLINICAL STUDY; MAJOR DEPRESSION; MALE; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL;

ADULT; ANTIDEPRESSIVE AGENTS; CASE-CONTROL STUDIES; CHEMOKINE CCL2; CHEMOKINE CCL4; CHEMOKINES; DEPRESSIVE DISORDER, MAJOR; FEMALE; HUMANS; INTERLEUKIN-8; MALE; MIDDLE AGED; MODELS, STATISTICAL; MULTIVARIATE ANALYSIS;

EID: 73949158447     PISSN: 03064530     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.psyneuen.2009.06.007     Document Type: Article

References (35)

1. American Psychiatric Association. Diagnostic and Statistical Manual of Mental Disorders. 4th edn (1994), DSM-IV, Washington, DC
2. Babyak M.A. What you see may not be what you get: a brief, nontechnical introduction to overfitting in regression-type models. Psychosom. Med. 66 (2004) 411-421
3. Baggiolini M. Chemokines and leukocyte traffic. Nature 392 (1998) 565-568
4. Beck A.T., Ward C.H., Mendelson M., Mock J., and Erbaugh J. An inventory for measuring depression. Arch. Gen. Psychiatry 4 (1961) 561-571
5. Cyranowski J.M., Marsland A.L., Bromberger J.T., Whiteside T.L., Chang Y., and Matthews K.A. Depressive symptoms and production of proinflammatory cytokines by peripheral blood mononuclear cells stimulated in vitro. Brain Behav. Immun. 21 (2007) 229-237
6. de Haas A.H., van Weering H.R., de Jong E.K., Boddeke H.W., and Biber K.P. Neuronal chemokines: versatile messengers in central nervous system cell interaction. Mol. Neurobiol. 36 (2007) 137-151
7. de Jager W., te Velthuis H., Prakken B.J., Kuis W., and Rijkers G.T. Simultaneous detection of 15 human cytokines in a single sample of stimulated peripheral blood mononuclear cells. Clin. Diagn. Lab. Immunol. 10 (2003) 133-139
8. Elshal M.F., and McCoy J.P. Multiplex bead array assays: performance evaluation and comparison of sensitivity to ELISA. Methods 38 (2006) 317-323
9. Guyon, A., Skrzydelski, D., De Giry, I., Rovère, C., Conductier, G., Trocello, J.M., Daugé, V., Kitabgi, P., Rostène, W., Nahon, J.L., Parsadaniantz, S.M., in press. Long term exposure to the chemokine CCL2 activates the nigrostriatal dopamine system: a novel mechanism for the control of dopamine release. Neuroscience, doi:10.1016/j.neuroscience.2009.05.048.
10. Joukamaa M., Miettunen J., Kokkonen P., Koskinen M., Julkunen J., Kauhanen J., Jokelainen J., Veijola J., Läksy K., and Järvelin M.R. Psychometric properties of the Finnish 20-item Toronto Alexithymia Scale. Nord. J. Psychiatry 55 (2001) 123-127
11. Kahl K.G., Rudolf S., Stoeckelhuber B.M., Dibbelt L., Gehl H.B., Markhof K., Hohagen F., and Schweiger U. Bone mineral density, markers of bone turnover, and cytokines in young women with borderline personality disorder with and without comorbid major depressive disorder. Am. J. Psychiatry 162 (2005) 168-174
12. Khan I.H., Krishnan V.V., Ziman M., Janatpour K., Wun T., Luciw P.A., and Tuscano J. A comparison of multiplex suspension array large-panel kits for profiling cytokines and chemokines in rheumatoid arthritis patients. Cytometry B: Clin. Cytom. 76B (2008) 159-168
13. Khan S.S., Smith M.S., Reda D., Suffredini A.F., and McCoy Jr. J.P. Multiplex bead array assays for detection of soluble cytokines: comparisons of sensitivity and quantitative values among kits from multiple manufacturers. Cytometry B: Clin. Cytom. 61 (2004) 35-39
14. Koivumaa-Honkanen H.T., Honkanen R., Viinamäki H., Heikkilä K., Kaprio J., and Koskenvuo M. Self-reported life satisfaction and 20-year mortality in healthy Finnish adults. Am. J. Epidemiol. 152 (2000) 983-991
15. Kronfol Z., and Remick D.G. Cytokines and the brain: implications for clinical psychiatry. Am. J. Psychiatry 157 (2000) 683-694
16. Leng S.X., McElhaney J.E., Walston J.D., Xie D., Fedarko N.S., and Kuchel G.A. ELISA and multiplex technologies for cytokine measurement in inflammation and aging research. J. Gerontol. A: Biol. Sci. Med. Sci. 63 (2008) 879-884
17. Li M., and Ransohoff R.M. Multiple roles of chemokine CXCL12 in the central nervous system: a migration from immunology to neurobiology. Prog. Neurobiol. 84 (2008) 116-131
18. Madrigal J.L., Leza J.C., Polak P., Kalinin S., and Feinstein D.L. Astrocyte-derived MCP-1 mediates neuroprotective effects of noradrenaline. J. Neurosci. 29 (2009) 263-267
19. Maes M., Meltzer H.Y., Bosmans E., Bergmans R., Vandoolaeghe E., Ranjan R., and Desnyder R. Increased plasma concentrations of interleukin-6, soluble interleukin-6, soluble interleukin-2 and transferrin receptor in major depression. J. Affect. Disord. 34 (1995) 301-309
20. Merikangas K.R., Zhang H., Avenevoli S., Acharyya S., Neuenschwander M., Angst J., and Zurich Cohort Study. Longitudinal trajectories of depression and anxiety in a prospective community study: the Zurich Cohort Study. Arch. Gen. Psychiatry 60 (2003) 993-1000
21. Miller A.H., Maletic V., and Raison C.L. Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression. Biol. Psychiatry 65 (2009) 732-741
22. Podlipny, J., Hess, Z., Vrzalova, J., Rosolova, H., Beran, J., Petrlova, B., in press. Lower serum levels of interleukin-6 in a population sample with symptoms of depression than in a population sample without symptoms of depression. Physiol. Res.
23. Raison C.L., Capuron L., and Miller A.H. Cytokines sing the blues: inflammation and the pathogenesis of depression. Trends Immunol. 27 (2006) 24-31
24. Rollins B.J. Chemokines. Blood 90 (1997) 909-928
25. Rothenbacher D., Müller-Scholze S., Herder C., Koenig W., and Kolb H. Differential expression of chemokines, risk of stable coronary heart disease, and correlation with established cardiovascular risk markers. Arterioscler. Thromb. Vasc. Biol. 26 (2006) 194-199
26. Schiepers O.J., Wichers M.C., and Maes M. Cytokines and major depression. Prog. Neuropsychopharmacol. Biol. Psychiatry 29 (2005) 201-217
27. Simon N.M., McNamara K., Chow C.W., Maser R.S., Papakostas G.I., Pollack M.H., Nierenberg A.A., Fava M., and Wong K.K. A detailed examination of cytokine abnormalities in major depressive disorder. Eur. Neuropsychopharmacol. 18 (2008) 230-233
28. Skrzydelski D., Guyon A., Daugé V., Rovère C., Apartis E., Kitabgi P., Nahon J.L., Rostène W., and Parsadaniantz S.M. The chemokine stromal cell-derived factor-1/CXCL12 activates the nigrostriatal dopamine system. J. Neurochem. 102 (2007) 1175-1183
29. Stewart, J.C., Rand, K.L., Muldoon, M.F., Kamarck, T.W., in press. A prospective evaluation of the directionality of the depression-inflammation relationship. Brain Behav. Immun., doi:10.1016/j.bbi.2009.04.011.
30. Suarez E.C., Krishnan R.R., and Lewis J.G. The relation of severity of depressive symptoms to monocyte-associated proinflammatory cytokines and chemokines in apparently healthy men. Psychosom. Med. 65 (2003) 362-368
31. Suarez E.C., Lewis J.G., Krishnan R.R., and Young K.H. Enhanced expression of cytokines and chemokines by blood monocytes to in vitro lipopolysaccharide stimulation are associated with hostility and severity of depressive symptoms in healthy women. Psychoneuroendocrinology 29 (2004) 1119-1128
32. Sutcigil L., Oktenli C., Musabak U., Bozkurt A., Cansever A., Uzun O., Sanisoglu S.Y., Yesilova Z., Ozmenler N., Ozsahin A., and Sengul A. Pro- and anti-inflammatory cytokine balance in major depression: effect of sertraline therapy. Clin. Dev. Immunol. (2007) 76396
33. Viinamäki H., Heiskanen T., Lehto S.M., Niskanen L., Koivumaa-Honkanen H., Tolmunen T., Honkalampi K., Saharinen T., Haatainen K., and Hintikka J. Depressive symptoms are associated with metabolic syndrome in men. Acta Psychiatr. Scand. 120 (2009) 23-29
34. Whooley M.A., Caska C.M., Hendrickson B.E., Rourke M.A., Ho J., and Ali S. Depression and inflammation in patients with coronary heart disease: findings from the Heart and Soul Study. Biol. Psychiatry 62 (2007) 314-320
35. Williams J.B.W., and Terman M. Structured interview guide for the Hamilton Depression Rating Scale with Atypical Depression Supplement (SIGH-ADS) (2003), New York State Psychiatric Institute, New York